Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Kathy Petoumenos

Dados Biográficos

ID5554681
NOMEKathy Petoumenos
PRENOMESKathy
SOBRENOMEPetoumenos
ASSINATURAPETOUMENOS K
AFILIAÇÕESUNSW Sydney
ORCID0000-0001-7534-7154
VERIFICADOSim
TOTAL DE OBRAS6
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2015
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0
  • Self-reported and Point-of-Care Biomarkers of Substance Use Measures Among Older Adults with HIV from Low- and Middle-Income Countries

    Open Access•Kathryn E Lancaster, Melissa A Stockton et al.•ARTICLE•AIDS and Behavior•2026

    Measuring alcohol and other drug (AOD) use remains challenging in HIV care in low- and middle-income countries, where self-report and point-of-care (POC) urine biomarkers capture different time windows. Among 2,059 people with HIV aged 40 years or older across eight IeDEA clinics (2020 to 2022), we examined what self-reported AOD use (AUDIT, ASSIST) and POC urine tests (uEtG for alcohol; 5-panel drug screen) each capture. Self-report identified m…

  • Characteristics of heterosexually-acquired compared to homosexually-acquired HIV and implications for clinical practice

    Sophie Herbert, Rainer Puhr et al.•ARTICLE•AIDS Care•2022

    Heterosexuals living with HIV report feeling additional HIV stigma compared to homosexual men, which may affect clinical outcomes. Yet, beyond routinely collected surveillance data, little is known about the characteristics of individuals who acquire HIV heterosexually and clinical outcomes by mode of sexual acquisition have not been directly compared. Using data from the Australian HIV Observational Database, we compared clinical characteristics…

  • HIV treatment regimens and adherence to national guidelines in Australia

    Open Access•Nila J Dharan, Tomas Radovich et al.•ARTICLE•BMC Public Health•2019

    Australian HIV providers are prescribing ART regimens in accordance with updated treatment guidelines, but could further optimize regimens in the setting of important medical comorbidities

  • Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

    Open Access•J Grebely, Brian Conway et al.•ARTICLE•International Journal of Drug…•2018

  • Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men

    Open Access•Cecilia L Moore, Heather F Gidding et al.•ARTICLE•AIDS and Behavior•2016

  • Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs

    Open Access•Maryam Alavi, Tim Spelman et al.•ARTICLE•International Journal of Drug…•2015

Sem obras proeminentes nesta página.

  • Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs

    Open Access•Maryam Alavi, Tim Spelman et al.•ARTICLE•International Journal of Drug…•2015

  • Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men

    Open Access•Cecilia L Moore, Heather F Gidding et al.•ARTICLE•AIDS and Behavior•2016

  • Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

    Open Access•J Grebely, Brian Conway et al.•ARTICLE•International Journal of Drug…•2018

  • HIV treatment regimens and adherence to national guidelines in Australia

    Open Access•Nila J Dharan, Tomas Radovich et al.•ARTICLE•BMC Public Health•2019

    Australian HIV providers are prescribing ART regimens in accordance with updated treatment guidelines, but could further optimize regimens in the setting of important medical comorbidities

  • Characteristics of heterosexually-acquired compared to homosexually-acquired HIV and implications for clinical practice

    Sophie Herbert, Rainer Puhr et al.•ARTICLE•AIDS Care•2022

    Heterosexuals living with HIV report feeling additional HIV stigma compared to homosexual men, which may affect clinical outcomes. Yet, beyond routinely collected surveillance data, little is known about the characteristics of individuals who acquire HIV heterosexually and clinical outcomes by mode of sexual acquisition have not been directly compared. Using data from the Australian HIV Observational Database, we compared clinical characteristics…

  • Self-reported and Point-of-Care Biomarkers of Substance Use Measures Among Older Adults with HIV from Low- and Middle-Income Countries

    Open Access•Kathryn E Lancaster, Melissa A Stockton et al.•ARTICLE•AIDS and Behavior•2026

    Measuring alcohol and other drug (AOD) use remains challenging in HIV care in low- and middle-income countries, where self-report and point-of-care (POC) urine biomarkers capture different time windows. Among 2,059 people with HIV aged 40 years or older across eight IeDEA clinics (2020 to 2022), we examined what self-reported AOD use (AUDIT, ASSIST) and POC urine tests (uEtG for alcohol; 5-panel drug screen) each capture. Self-report identified m…

Medicine (5 obras) · HIV/AIDS Research and Interventions (4 obras) · Internal Medicine (4 obras) · Hepatitis C (3 obras) · HIV/AIDS drug development and treatment (3 obras) · Psychiatry (3 obras) · Drug (2 obras) · Family medicine (2 obras) · Health psychology (2 obras) · Hepatitis C virus (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae